Cargando…
Sulforaphane decreases serum selenoprotein P levels through enhancement of lysosomal degradation independent of Nrf2
Selenoprotein P (SeP) is a major selenoprotein in serum predominantly produced in the liver. Excess SeP impairs insulin secretion from the pancreas and insulin sensitivity in skeletal muscle, thus inhibition of SeP could be a therapeutic strategy for type 2 diabetes. In this study, we examine the ef...
Autores principales: | Ye, Xinying, Toyama, Takashi, Taguchi, Keiko, Arisawa, Kotoko, Kaneko, Takayuki, Tsutsumi, Ryouhei, Yamamoto, Masayuki, Saito, Yoshiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587141/ https://www.ncbi.nlm.nih.gov/pubmed/37857700 http://dx.doi.org/10.1038/s42003-023-05449-y |
Ejemplares similares
-
An efficient selenium transport pathway of selenoprotein P utilizing a high-affinity ApoER2 receptor variant and being independent of selenocysteine lyase
por: Mizuno, Ayako, et al.
Publicado: (2023) -
Identification of a novel endogenous long non-coding RNA that inhibits selenoprotein P translation
por: Mita, Yuichiro, et al.
Publicado: (2021) -
Selenoprotein P as an in vivo redox regulator: disorders related to its deficiency and excess
por: Saito, Yoshiro
Publicado: (2020) -
The Yin and Yang of Nrf2-Regulated Selenoproteins in Carcinogenesis
por: Brigelius-Flohé, Regina, et al.
Publicado: (2012) -
Selenium Transport Mechanism via Selenoprotein P—Its Physiological Role and Related Diseases
por: Saito, Yoshiro
Publicado: (2021)